Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year Type CMS eCQM ID Measure Name
2023 EC CMS136v12 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2022 EC CMS136v11 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2024 EC CMS135v12 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 EC CMS135v11 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2022 EC CMS135v10 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2022 EC CMS134v10 Diabetes: Medical Attention for Nephropathy
2024 EC CMS133v12 Cataracts: 20 over 40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2023 EC CMS133v11 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2022 EC CMS133v10 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2024 EC CMS131v12 Diabetes: Eye Exam
2023 EC CMS131v11 Diabetes: Eye Exam
2022 EC CMS131v10 Diabetes: Eye Exam
2024 EC CMS130v12 Colorectal Cancer Screening
2023 EC CMS130v11 Colorectal Cancer Screening
2022 EC CMS130v10 Colorectal Cancer Screening
2024 EC CMS129v13 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2023 EC CMS129v12 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2022 EC CMS129v11 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2024 EC CMS128v12 Anti-depressant Medication Management
2023 EC CMS128v11 Anti-depressant Medication Management